Journal article
High-Administered Activity In-111 Octreotide Therapy with Concomitant Radiosensitizing 5FU Chemotherapy for Treatment of Neuroendocrine Tumors: Preliminary Experience
Grace Kong, Val Johnston, Shakher Ramdave, Eddie Lau, Danny Rischin, Rodney J Hicks
Cancer Biotherapy & Radiopharmaceuticals | MARY ANN LIEBERT, INC | Published : 2009
